Docosahexaenoic acid antagonizes palmitate‐induced protein degradation in myotubes

Myra Woodworth‐Hobbs,Matt Hudson,Bin Zheng,Sara Zoromsky,Harold Franch,S. Russ Price
DOI: https://doi.org/10.1096/fasebj.27.1_supplement.940.16
2013-04-01
The FASEB Journal
Abstract:Muscle atrophy is a debilitating consequence of many chronic diseases, some of which are characterized by accumulation of lipids in skeletal muscle. High levels of saturated fatty acids (i.e. palmitic acid, PA) cause dysregulated protein metabolism in cultured myotubes, whereas the omega‐3 fatty acid docosahexaenoic acid (DHA) has beneficial metabolic effects. We hypothesized that DHA prevents PA‐induced muscle atrophy by counteracting its effects on protein degradation. To test our hypothesis, we studied C2C12 myotubes treated with 500uM PA and/or 100uM DHA. PA significantly increases the rate of protein degradation, and the response is reversed by co‐treatment with DHA. The protein kinase Akt is a key regulator of protein balance and inhibits the FoxO3 transcription factor. PA reduces the ratio of phospho‐to‐total Akt and increases the mRNA and total and nuclear protein levels of FoxO3. It also increases the levels of mRNA encoding three FoxO3 targets, the MuRF‐1 and atrogin‐1/MAFbx E3 ubiquitin ligases and the autophagy mediator Bnip3. DHA attenuates the effects of PA on Akt, FoxO3, and all three atrogenes mRNAs. These data indicate that PA induces protein degradation by inducing the ubiquitin‐proteasome and autophagic proteolytic systems and that DHA counters the catabolic effects of PA by improving Akt signaling. Support NIH DK95610, AHA GRNT 7660020
What problem does this paper attempt to address?